Cite
Ibrutinib as a bridge to transplant in high-risk chronic lymphocytic leukemia: A case report and review of the literature
MLA
Arcari Annalisa, et al. “Ibrutinib as a Bridge to Transplant in High-Risk Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature.” Leukemia Research Reports, vol. 8, no. C, Jan. 2017, pp. 21–23. EBSCOhost, https://doi.org/10.1016/j.lrr.2017.11.001.
APA
Arcari Annalisa, Bassi Simona, Pochintesta Lara, Trabacchi Elena, Moroni Carlo Filippo, Rossi Angela, Zanlari Luca, & Vallisa Daniele. (2017). Ibrutinib as a bridge to transplant in high-risk chronic lymphocytic leukemia: A case report and review of the literature. Leukemia Research Reports, 8(C), 21–23. https://doi.org/10.1016/j.lrr.2017.11.001
Chicago
Arcari Annalisa, Bassi Simona, Pochintesta Lara, Trabacchi Elena, Moroni Carlo Filippo, Rossi Angela, Zanlari Luca, and Vallisa Daniele. 2017. “Ibrutinib as a Bridge to Transplant in High-Risk Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature.” Leukemia Research Reports 8 (C): 21–23. doi:10.1016/j.lrr.2017.11.001.